Navigation Links
Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
Date:5/19/2008

Ernst & Young's 2008 Global Biotechnology Report reveals robust investment

in the industry; sweeping trends that are transforming the industry

BOSTON, May 20 /PRNewswire/ -- The global biotechnology industry achieved record levels in financing and deal making in 2007, as investors and strategic partners showed strong confidence in the sector amid tightening global financial conditions that will continue to test the industry in 2008. These and other findings were highlighted in Beyond Borders: Global Biotechnology Report 2008, Ernst & Young's annual report on the trends shaping the biotechnology industry, released today.

"In 2007, investors were drawn to the tremendous value of biotech's innovation, with impressive results, as venture financing and deal making reached unprecedented heights," said Glen Giovannetti, Ernst & Young's Global Biotechnology Leader. "To continue its multi-year track record of progress, the industry must meet the current challenges of cooling public equity markets, greater regulatory scrutiny and higher product approval and reimbursement hurdles with fiscal discipline and the creativity and innovation for which it is known."
Key industry findings described in the report include:

-- The global biotechnology industry had a very strong year on the

financing front. Companies in the Americas and Europe raised more than

US$29.9 billion -- a new high excluding the outlier genomics bubble

year of 2000.

-- Venture financing reached an all-time high in 2007 with investment

totaling about US$7.5 billion, fueled by a record total of US$5.5

billion in the US and 72% growth in Canada.

-- Global public biotechnology company revenue rose by 8% in 2007,

crossing the US$80 billion threshold for the first time. Absent the

acquisition of several leading biotech revenue producers by big pharma,

revenue would have increased by about 17% -- i
'/>"/>

SOURCE Ernst & Young
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. New efficiency record for solar cells
2. First electrophysical recording of sleep in a wild animal
3. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
4. ATS Medical Announces Record Quarterly Revenue and Gross Profit
5. Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
6. Dilon Technologies Closes First Quarter With Record Sales
7. Bioscience Career Fair in San Francisco Projected to Break Job Seeker Attendance Records
8. Laureate Pharma Reports Record Growth for 2007
9. Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance
10. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
11. Photonic Products Group, Inc. Reports Record Financial Results for FY 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Boston, MA (PRWEB) November 26, 2014 ... and collaboration company is proud to announce that Darren ... Development and Sales. Darren will drive the ... and positive customer experience. , Darren brings ... He has held key roles in channel operations, from ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... Acid Industry is an in-depth research report on ... analysis, the report introduces Palmitic Acid, basic information, ... overview, policy analysis, and news analysis, etc. ... report analyzes Palmitic Acid market in ...
(Date:11/26/2014)... 25, 2014 Bio-Techne Corporation (NASDAQ: ... Robert Gavin to serve in a newly created ... Division.  Mr. Gavin will be responsible for managing the ... the ProteinSimple business acquired in July 2014 and the ... Jose, California -based ProteinSimple develops and commercializes proprietary ...
(Date:11/26/2014)... WARREN, N.J. , Nov. 25, 2014  Roka Bioscience, ... focused on providing advanced testing solutions for the detection of ... will present at the Piper Jaffray  26 th Annual ... conference will be held at The New York Palace in ... During this presentation, material information concerning the Company, its operations, ...
Breaking Biology Technology:SoundConnect Appoints Director of Channel Development & Sales 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2
... N.Y. Rensselaer Polytechnic Institute is leading a $3 ... worlds most powerful supercomputers to boost the safety and ... project, funded by the U.S. Department of Energy, will ... to create highly detailed computer models of a new ...
... Pharmasset, Inc.,(Nasdaq: VRUS ) appointed ... Chief,Development Officer, responsible for coordinating the global ... Dr. Rogers joins,Pharmasset from GlaxoSmithKline, where he ... Viral Diseases, responsible for antiviral discovery,activities directed ...
... (Nasdaq: NPSP ) today reported its financial results ... update on its 2007 milestones and,financial guidance. Update ... partnership with Nycomed to develop,GATTEX(TM) (teduglutide) outside North America, ... corporate milestones for 2007. The company announced that it,has: ...
Cached Biology Technology:Using supercomputers to make safer nuclear reactors 2Using supercomputers to make safer nuclear reactors 3Using supercomputers to make safer nuclear reactors 4Pharmasset Appoints Michael Rogers as Chief Development Officer 2Pharmasset Appoints Michael Rogers as Chief Development Officer 3NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 2NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 3NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 4NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 5NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 6NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 7NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 8NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance 9
(Date:11/4/2014)... – A majority of Madagascar,s 101 species of lemurs ... consequences for the rainforests they call home. A new ... lemurs can have on rainforest tree populations, which raises ... on the region,s rich biodiversity. , A large proportion ... lemurs. Lemurs in turn disperse the seeds of ...
(Date:11/3/2014)... Nov. 3, 2014 Research and Markets ... Therapy - Technologies, Markets and Companies" to their offering. ... technologies and methods, which have already started to play an ... transplantation is replacing the old fashioned bone marrow transplants. Role ... is bound to become a part of medical practice. ...
(Date:11/3/2014)...  NeuroSigma ® , Inc. (NeuroSigma), a ... on commercialization of its non-invasive Monarch ... neurological and neuropsychiatric disorders, announced today that the ... Notice of Allowance for Mexican Patent Application No. ... and the Regents of the University of California ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... new report that a major experiment be conducted to reintroduce ... help control the populations and behavior of red deer that ... of large ecosystems. The proposal is modeled after research ... elsewhere, which has demonstrated that the absence of large predators ...
... Nanoparticles are just billionths of a millimeter in size. Exhibiting ... into an endless stream of equally innovative products. In medical ... or even genes into cells. So far, the only way ... desired effect to show the activation of a transported ...
... 20 July 2009: Research at the University of Liverpool has ... protect buildings from earthquakes. The seismic waves produced ... and surface waves which travel across it. The new technology ... damaging and responsible for much of the destruction which follows ...
Cached Biology News:Wolf reintroduction proposed in Scottish Highland test case 2Wolf reintroduction proposed in Scottish Highland test case 3Chasing tiny vehicles 2Chasing tiny vehicles 3'Invisibility cloak' could protect against earthquakes 2
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Inquire...
... Detection Kit is intended for quantitative detection ... peptides, which can result from the gradual, ... aspartic acid residues during storage or handling. ... the monitoring of charge differences for detection, ...
...
Biology Products: